Division of Pulmonary, Allergy
and Critical Care Medicine
Research Laboratories
Associate
Professor of Medicine and Public Health
Chief,
Division of Pulmonary, Allergy, and Critical Care Medicine
|
|
Laboratory Address 622 Phone 212-305-9817 Fax
212-305-8464 |
|
|
|
|
Dr. Schluger's research
focuses on several aspects of tuberculosis, including molecular epidemiology,
novel diagnostics, and clinical trials. Clinical trials: Dr. Schluger is the
Steering Committee Chairman of the Tuberculosis Trials Consortium, a
CDC-funded international research consortium with 30 sites in 5 countries.
This consortium conducts a variety of phase II and phase III clinical trials
of treatments for latent and active tuberculosis. Dr. Schluger is also the principal
investigator for the Molecular epidemiology:
Using a database which combines clinical and demographic variables about
tuberculosis patients in Northern Manhattan, and
analyzing these data against RFLP patterns of M. tuberculosis isolates from
those same patients, he has demonstrated important findings about the
transmission of tuberculosis in Novel diagnostics: Dr.
Schluger has a long interest in novel diagnostic methods for tuberculosis,
and is currently evaluating the utility of the T-Spot ELISPOT assay, which stimulates
peripheral blood mononuclear cells with M. tuberculosis specific antigens, in
the assessment of close contacts of tuberculosis patients and other groups at
high risk for latent infection. |
|
© Columbia University,